Dynavax (DVAX) Reports Q3 Loss of $0.24/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Dynavax Technologies (DVAX) PT Raised to $30 at Cowen
November 5, 2021 6:45 AM EDTCowen analyst Phil Nadeau raised the price target on Dynavax Technologies (NASDAQ: DVAX) to $30.00 (from $20.00) while maintaining an Outperform rating.
The analyst commented, "DVAX reported Q3 Heplisav rev. of $22.7MM, above consensus ($15MM) as share at targeted accounts increased to... More
